Showing 91-100 of 106 results for "".
- Christie Brinkley Partners with Merz to Launch New “Milestones of Me” Campaignhttps://modernaesthetics.com/news/christie-brinkley-partners-with-merz-to-launch-new-milestones-of-me-campaign/2471958/Merz Americas is partnering with supermodel, actress, and entrepreneur, Christie Brinkley, to launch a new campaign, “Milestones of Me,” which encourages women to celebrate the moments, big or small, that have made them who they are today. The campaign kicks off in honor of Christie&r
- Milestone Scientific Gears Up To Launch New Botox Delivery Instrumenthttps://modernaesthetics.com/news/milestone-scientific-gears-up-to-launch-new-botox-delivery-instrument/2472162/Botulinum toxin injections may be about to get smarter and more comfortable as Milestone Scientific Inc. readies to launch its novel and proprietary cosmetic injection instrument. The new cosmetic injection instrument
- The Aesthetic Society Announces Major Milestone, New Educational Opportunitieshttps://modernaesthetics.com/news/the-aesthetic-society-announces-major-milestone-new-educational-opportunities/2473711/The Aesthetic Society announced a “historic” expansion of its Global Alliance Partners program on Tuesday. The society has secured partnerships with 31 distinguished international aesthetic surgery organizations through Memorandum of Understanding (MOU) agreements. &qu
- Merz Aesthetics Marks 15 Years of XEOMIN® With New National Campaignhttps://modernaesthetics.com/news/merz-aesthetics-marks-15-years-of-xeomin-with-new-national-campaign/2485650/Merz Aesthetics is commemorating 15 years since the US Food and Drug Administration (FDA) approved XEOMIN® (incobotulinumtoxinA) for aesthetic use, marking a milestone for the company’s flagship neurotoxin in the competitive US injectable market. Approved f
- Octane Aesthetics Tech Forum Panelists React to FDA Approval of Oral Semaglutidehttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-panelists-react-to-fda-approval-of-oral-semaglutide/2485572/At the 2026 Octane Aesthetics Tech Forum, panelists weighed in on the recent FDA approval of oral semaglutide, offering a mix of cautious optimism and clinical realism. While the approval marks a milestone in expanding GLP-1 receptor agonist (RA) access, most experts on the panel said oral versio
- Daxxify® Surpasses 1 Million Vials Distributed in US Aesthetic Markethttps://modernaesthetics.com/news/daxxify-surpasses-1-million-vials-distributed-in-us-aesthetic-market/2483419/Revance Therapeutics has announced the distribution of more than 1 million vials of daxibotulinumtoxinA-lanm (Daxxify®) for aesthetic use in the United States, marking a notable milestone 3 years after the product received US Food and Drug Administration (FDA) approval. According to a pres
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://modernaesthetics.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- DefenAge 360-Rejuvenation Nail Root Serum Earns Allure Awardhttps://modernaesthetics.com/news/defenage-360-rejuvenation-nail-root-serum-earns-allure-award/2473680/DefenAge® Skincare’s 360-Rejuvenation Nail Root Serum earned a 2024 Allure Best of Beauty Award, DefenAge announced. “This recognition marks a significant milestone for the brand,” the company said in a press release, “solidifying its commitment to delivering
- Evolus to Ring Nasdaq Stock Market Closing Bell On September 13https://modernaesthetics.com/news/evolus-to-ring-nasdaq-stock-market-closing-bell-on-september-13/2473667/Evolus Inc. announced the company will be ringing the Nasdaq closing bell on Friday, September 13. The Nasdaq closing bell ceremony is a time-honored tradition, serving as a platform for companies to celebrate achievements and milestones. “We are honored to h
- Letybo (letibotulinumtoxinA-wlbg) Receives FDA Approvalhttps://modernaesthetics.com/news/fda-grants-approval-for-letybo-letibotulinumtoxina-wlbg/2473551/Hugel America, Inc., announced the achievement of a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for its neurotoxin, Letybo. "We are thrilled with the FDA's approval of Letybo. This is a huge achievement for Hugel as we